妇炎康联合阿奇霉素治疗盆腔炎性疾病的临床观察
2021-12-13王春凤
王春凤

【摘 要】目的:研究观察针对临床收治盆腔炎疾病患者在治疗过程中开展联合治疗方式(阿奇霉素配合妇炎康)治疗价值。方法:240例盆腔炎患者样本纳入时间由2017年1月开始,到2018年1月结束,随机均分为120例开展单纯阿奇霉素治疗(对照组)与120例开展联合治疗方式(阿奇霉素配合妇炎康)治疗(观察组),对照分析两组临床情况。结果:观察组总有效率高于对照组(P<0.05)。结论:针对临床收治盆腔炎疾病患者在治疗过程中开展联合治疗方式(阿奇霉素配合妇炎康)治疗是可行的,不仅能够显著增强整体临床治疗效果。
【关键词】盆腔炎;联合治疗;阿奇霉素;妇炎康
Clinical observation of Fuyankang combined with azithromycin in the treatment of pelvic inflammatory diseases
Wang Chunfeng
ShouguangLuocheng Street Health Center ,Shandong Shouguang 262700,China
【Abstract】Objective:To study and observe the therapeutic value of combined therapy (Azithromycin combined with Fuyankang) in the treatment of patients with pelvic inflammatory disease. Methods: 240 patients with pelvic inflammatory disease were included from January 2017 to January 2018. They were randomly divided into 120 cases treated with azithromycin alone (control group) and 120 cases treated with combined treatment (Azithromycin combined with Fuyankang) (observation group). The clinical conditions of the two groups were compared and analyzed. Results: the total effective rate of the observation group was higher than that of the control group (P < 0.05). Conclusion: it is feasible to carry out combined treatment (Azithromycin combined with Fuyankang) in the treatment of patients with pelvic inflammatory disease, which can not only significantly enhance the overall clinical treatment effect.
【Key?Words】Pelvic inflammatory disease; Combination therapy; Azithromycin; Fu Yankang
盆腔炎性疾病是由于女性患者自身生殖器、四周结缔组织与盆腔腹膜之間产生炎症,从而引发的一种疾病。主要集中于月经女性,对于初潮前、绝经后以及无性生活女性而言,发病率相对较低。该疾病分别包括输卵管炎、子宫内膜炎或者是盆腔腹膜炎[1]。据有关研究报道指出,随着国内生活经济水平持续上升,促使国内每年女性新发生殖系统疾病发病率持续上涨,导致女性患者出现不孕或者是异位妊娠,对女性患者日常生活以及身体健康等造成严重威胁。月经失调、腰骶部疼痛、下腹部疼痛以及坠胀感是该疾病主要临床症状表现,同时还会伴有白带增多[2]。当前,西医临床针对该疾病主要以甲硝唑或者是阿奇霉素治疗为主,但以上两种药物效果并不突出。因此,为了确保盆腔炎疾病患者病情能够快速康复,临床决定推行更有效联合治疗方案[3]。鉴于此,本研究观察针对临床收治盆腔炎疾病患者在治疗过程中开展联合治疗方式(阿奇霉素配合妇炎康)治疗价值,内容如下。……
